SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-12-001675
Filing Date
2012-11-14
Accepted
2012-11-14 14:07:05
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 bazi10q09302012.htm 10-Q 437533
2 ex31-1.htm EX-31.1 13081
3 ex31-2.htm EX-31.2 13105
4 ex32-1.htm EX-32.1 5597
5 ex32-2.htm EX-32.2 5720
  Complete submission text file 0001415889-12-001675.txt   2176294

Data Files

Seq Description Document Type Size
6 bazi-20120930.xml EX-101.INS 185651
7 bazi-20120930.xsd EX-101.SCH 32244
8 bazi-20120930_pre.xml EX-101.PRE 109339
9 bazi-20120930_lab.xml EX-101.LAB 176122
10 bazi-20120930_def.xml EX-101.DEF 10005
11 bazi-20120930_cal.xml EX-101.CAL 31406
Mailing Address 1730 BLAKE STREET, SUITE 305 DENVER CO 80202
Business Address 1730 BLAKE STREET, SUITE 305 DENVER CO 80202 303 316-8577
BAZI INTERNATIONAL, INC. (Filer) CIK: 0001134765 (see all company filings)

IRS No.: 841575085 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32420 | Film No.: 121203138
SIC: 2833 Medicinal Chemicals & Botanical Products